Literature DB >> 30056170

A bidirectional crosstalk between glioblastoma and brain endothelial cells potentiates the angiogenic and proliferative signaling of sphingosine-1-phosphate in the glioblastoma microenvironment.

Loubna Abdel Hadi1, Viviana Anelli1, Laura Guarnaccia2, Stefania Navone2, Matteo Beretta2, Francesco Moccia3, Cristina Tringali1, Vasile Urechie1, Rolando Campanella2, Giovanni Marfia2, Laura Riboni4.   

Abstract

Glioblastoma is one of the most malignant, angiogenic, and incurable tumors in humans. The aberrant communication between glioblastoma cells and tumor microenvironment represents one of the major factors regulating glioblastoma malignancy and angiogenic properties. Emerging evidence implicates sphingosine-1-phosphate signaling in the pathobiology of glioblastoma and angiogenesis, but its role in glioblastoma-endothelial crosstalk remains largely unknown. In this study, we sought to determine whether the crosstalk between glioblastoma cells and brain endothelial cells regulates sphingosine-1-phosphate signaling in the tumor microenvironment. Using human glioblastoma and brain endothelial cell lines, as well as primary brain endothelial cells derived from human glioblastoma, we report that glioblastoma-co-culture promotes the expression, activity, and plasma membrane enrichment of sphingosine kinase 2 in brain endothelial cells, leading to increased cellular level of sphingosine-1-phosphate, and significant potentiation of its secretion. In turn, extracellular sphingosine-1-phosphate stimulates glioblastoma cell proliferation, and brain endothelial cells migration and angiogenesis. We also show that, after co-culture, glioblastoma cells exhibit enhanced expression of S1P1 and S1P3, the sphingosine-1-phosphate receptors that are of paramount importance for cell growth and invasivity. Collectively, our results envision glioblastoma-endothelial crosstalk as a multi-compartmental strategy to enforce pro-tumoral sphingosine-1-phosphate signaling in the glioblastoma microenvironment.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Brain endothelial cells; Glioblastoma cells; Sphingosine kinase 2; Sphingosine-1-phosphate

Mesh:

Substances:

Year:  2018        PMID: 30056170     DOI: 10.1016/j.bbalip.2018.07.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  7 in total

Review 1.  The Vascular Microenvironment in Glioblastoma: A Comprehensive Review.

Authors:  Alejandra Mosteiro; Leire Pedrosa; Abel Ferrés; Diouldé Diao; Àngels Sierra; José Juan González
Journal:  Biomedicines       Date:  2022-05-31

2.  Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.

Authors:  Rolando Campanella; Laura Guarnaccia; Chiara Cordiglieri; Elena Trombetta; Manuela Caroli; Giorgio Carrabba; Nicla La Verde; Paolo Rampini; Chiara Gaudino; Antonella Costa; Sabino Luzzi; Giovanna Mantovani; Marco Locatelli; Laura Riboni; Stefania Elena Navone; Giovanni Marfia
Journal:  Cells       Date:  2020-01-25       Impact factor: 6.600

Review 3.  Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks.

Authors:  Laura Riboni; Loubna Abdel Hadi; Stefania Elena Navone; Laura Guarnaccia; Rolando Campanella; Giovanni Marfia
Journal:  Cells       Date:  2020-02-01       Impact factor: 6.600

Review 4.  Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors.

Authors:  Federica Fabro; Martine L M Lamfers; Sieger Leenstra
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

Review 5.  Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate.

Authors:  Cyntanna C Hawkins; Tomader Ali; Sasanka Ramanadham; Anita B Hjelmeland
Journal:  Biomolecules       Date:  2020-09-23

6.  Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics.

Authors:  Laura Guarnaccia; Stefania E Navone; Matteo M Masseroli; Melissa Balsamo; Manuela Caroli; Silvia Valtorta; Rosa M Moresco; Rolando Campanella; Luigi Schisano; Giorgio Fiore; Valentina Galiano; Emanuele Garzia; Giuseppe C Appiani; Marco Locatelli; Laura Riboni; Giovanni Marfia
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

7.  Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.

Authors:  Giovanni Marfia; Stefania Navone; Laura Guarnaccia; Rolando Campanella; Michele Mondoni; Marco Locatelli; Alessandra Barassi; Laura Fontana; Fabrizio Palumbo; Emanuele Garzia; Giuseppe Ciniglio Appiani; Davide Chiumello; Monica Miozzo; Stefano Centanni; Laura Riboni
Journal:  EMBO Mol Med       Date:  2020-12-09       Impact factor: 14.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.